Related Experiment Video
Updated: Feb 14, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI
Hio Teng Cheong1, Fei Xu2, Chi Tung Choy1
1Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, P.R. China.
Abstract:
Lung cancer has the highest incidence and mortality rate worldwide among all malignancy-associated mortalities, of which non-small cell lung cancer accounts for 80% of all cases. Resistance against epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) develops following 8-12 months of disease progression, and is a critical issue. HCC827 cell lines with resistance to EGFR-TKIs were successfully screened. The half maximal inhibitory concentration values were 1,000-fold higher than the values for the parental HCC827 cell line, thereby demonstrating cross-resistance against the same family of TKIs. The expression of B-cell lymphoma 2 (Bcl2) was markedly increased in the resistant clones, as well as in the patient biopsies. The phosphatase and tensin homolog phosphoinositide 3-kinase signaling axis is a potential mechanism for acquiring resistance, and therefore targeting Bcl2 may be a useful strategy for further investigations.
Insights
Non-small cell lung cancer (NSCLC) patients develop resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs). Targeting B-cell lymphoma 2 (Bcl2) may overcome this resistance, offering a new therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide, with 80% of cases being NSCLC.
- Resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) is a significant clinical challenge, typically developing within 8-12 months of treatment.
- Understanding the mechanisms of acquired resistance is crucial for developing effective treatment strategies.
Purpose of the Study:
- To investigate the mechanisms underlying acquired resistance to EGFR-TKIs in NSCLC.
- To identify potential therapeutic targets to overcome EGFR-TKI resistance.
Main Methods:
- Screening and characterization of HCC827 cell lines exhibiting resistance to EGFR-TKIs.
- Quantification of half maximal inhibitory concentration (IC50) values to assess drug resistance.
- Analysis of B-cell lymphoma 2 (Bcl2) expression in resistant cell lines and patient biopsies.
- Investigation of the phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K) signaling axis.
Main Results:
- Resistant HCC827 cell lines demonstrated a 1,000-fold increase in IC50 values compared to parental cells, indicating significant cross-resistance to TKIs.
- Markedly increased expression of B-cell lymphoma 2 (Bcl2) was observed in resistant clones and patient biopsies.
- The PTEN/PI3K signaling axis was implicated as a potential mechanism contributing to acquired resistance.
Conclusions:
- Acquired resistance to EGFR-TKIs in NSCLC is associated with increased Bcl2 expression.
- The PTEN/PI3K pathway may play a role in the development of this resistance.
- Targeting Bcl2 represents a promising therapeutic strategy for overcoming EGFR-TKI resistance in NSCLC patients.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...